Europe Dengue Treatment Market to 2032
Overview
The Europe Dengue Treatment Market is expected to reach a 193.61 USD Million by 2032 and is projected to grow at a CAGR of 11.09% from 2025 to 2032.
Revenue, 2024 (USD Million)
91.62
Forecast, 2032 (USD Million)
193.61
CAGR, 2024 - 2032
11.09%
Report Coverage
Europe
Europe Dengue Treatment Market 2018-2032 USD Million
Europe Dengue Treatment Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 91.62 USD Million
- Projected Market Size (2032): 193.61 USD Million
- CAGR (2025-2032): 11.09%
Key Findings of Europe Dengue Treatment Market
- The Europe Dengue Treatment Market was valued at 91.62 USD Million in 2024.
- The Europe Dengue Treatment Market is likely to grow at a CAGR of 11.09% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Prescription in Mode of Purchase Segment accounted for the largest share of the market with a revenue of 76.19 USD Million
- The fastest growing segment Home Healthcare in End User Segment grew Fastest with a CAGR of 12.14% during the forecast period from 2024 to 2032.
Europe Dengue Treatment Market Scope
Europe Dengue Treatment Market Segmentation & Scope
Type
- Acetaminophen
- Vaccines
Strains
- Others
- DENV-4
- DENV-3
- DENV-2
- DENV-1
Severity
- Mild to Moderate Dengue
- Severe Dengue
Route of Administration
- Oral
- Parenteral
End User
- Hospital
- Specialty Clinics
- Home Healthcare
- Others
Age
- Geriatric
- Pediatric
- Adult
Gender
- Female
- Male
Mode of Purchase
- Over-The-Counter (OTC)
- Prescription
Distribution Channel
- Online Pharmacies
- Hospital Pharmacies
- Retail Pharmacies
Europe Dengue Treatment Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 91.62 USD Million |
| Market Value in 2032 | 193.61 USD Million |
| CAGR (2025-2032) | 11.09% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Type,Strains,Severity,Route of Administration,End User,Age,Gender,Mode of Purchase,Distribution Channel |
Regional Insights:
-
Leading Market (2024-2032): Europe, leading in terms of revenue 91.62 USD Million in 2024
- Key Country: France, leading in terms of revenue with value of 17.17 USD Million in 2024.
Segments and Scope
-
Europe Dengue Treatment Market to 2032, By Type
- Vaccines is the largest segment in Europe Dengue Treatment Market to 2032 with a revenue of 62.27 USD Million in the year 2024.
- Vaccines is the Fastest growing segment in Europe Dengue Treatment Market to 2032 with a Growth rate of 12.03 % in forecast period 2025-2032.
-
Europe Dengue Treatment Market to 2032, By Strains
- DENV-2 is the largest segment in Europe Dengue Treatment Market to 2032 with a revenue of 31.31 USD Million in the year 2024.
- DENV-1 is the Fastest growing segment in Europe Dengue Treatment Market to 2032 with a Growth rate of 10.80 % in forecast period 2025-2032.
-
Europe Dengue Treatment Market to 2032, By Severity
- Mild to Moderate Dengue is the largest segment in Europe Dengue Treatment Market to 2032 with a revenue of 55.25 USD Million in the year 2024.
- Mild to Moderate Dengue is the Fastest growing segment in Europe Dengue Treatment Market to 2032 with a Growth rate of 11.46 % in forecast period 2025-2032.
-
Europe Dengue Treatment Market to 2032, By Route of Administration
- Parenteral is the largest segment in Europe Dengue Treatment Market to 2032 with a revenue of 75.81 USD Million in the year 2024.
- Parenteral is the Fastest growing segment in Europe Dengue Treatment Market to 2032 with a Growth rate of 11.22 % in forecast period 2025-2032.
-
Europe Dengue Treatment Market to 2032, By End User
- Hospital is the largest segment in Europe Dengue Treatment Market to 2032 with a revenue of 52.49 USD Million in the year 2024.
- Home Healthcare is the Fastest growing segment in Europe Dengue Treatment Market to 2032 with a Growth rate of 11.37 % in forecast period 2025-2032.
-
Europe Dengue Treatment Market to 2032, By Age
- Adult is the largest segment in Europe Dengue Treatment Market to 2032 with a revenue of 52.62 USD Million in the year 2024.
- Pediatric is the Fastest growing segment in Europe Dengue Treatment Market to 2032 with a Growth rate of 10.70 % in forecast period 2025-2032.
-
Europe Dengue Treatment Market to 2032, By Gender
- Male is the largest segment in Europe Dengue Treatment Market to 2032 with a revenue of 65.20 USD Million in the year 2024.
- Male is the Fastest growing segment in Europe Dengue Treatment Market to 2032 with a Growth rate of 11.35 % in forecast period 2025-2032.
-
Europe Dengue Treatment Market to 2032, By Mode of Purchase
- Prescription is the largest segment in Europe Dengue Treatment Market to 2032 with a revenue of 76.19 USD Million in the year 2024.
- Prescription is the Fastest growing segment in Europe Dengue Treatment Market to 2032 with a Growth rate of 11.21 % in forecast period 2025-2032.
-
Europe Dengue Treatment Market to 2032, By Distribution Channel
- Retail Pharmacies is the largest segment in Europe Dengue Treatment Market to 2032 with a revenue of 47.68 USD Million in the year 2024.
- Online Pharmacies is the Fastest growing segment in Europe Dengue Treatment Market to 2032 with a Growth rate of 11.22 % in forecast period 2025-2032.
Europe Dengue Treatment Market Company Share Analysis
| Company Name |
|
||
| Viatris Inc. | |||
| Johnson & Johnson Services, Inc. | |||
| Takeda Pharmaceutical Company Limited | |||
| Sanofi | |||
| GSK plc. | |||
Europe Dengue Treatment Market Geographical Sales Distribution, 2018-2032 USD Million
Europe Dengue Treatment Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Europe Dengue Treatment Market is segmented based on Segmentation Type,Strains,Severity,Route of Administration,End User,Age,Gender,Mode of Purchase,Distribution Channel.
Europe Dengue Treatment Market was valued at USD 91.62(Revenue in USD Million) in 2022.
Europe Dengue Treatment Market is projected to grow at a CAGR of 11.09% during the forecast period of 2024 to 2032.
The Prescription segment is expected to dominate the Europe Dengue Treatment Market, holding a largest market share of 76.19 USD Million in 2024
Europe Dengue Treatment Market Scope
Europe Dengue Treatment Market Segmentation & Scope
Type
- Acetaminophen
- Vaccines
Strains
- Others
- DENV-4
- DENV-3
- DENV-2
- DENV-1
Severity
- Mild to Moderate Dengue
- Severe Dengue
Route of Administration
- Oral
- Parenteral
End User
- Hospital
- Specialty Clinics
- Home Healthcare
- Others
Age
- Geriatric
- Pediatric
- Adult
Gender
- Female
- Male
Mode of Purchase
- Over-The-Counter (OTC)
- Prescription
Distribution Channel
- Online Pharmacies
- Hospital Pharmacies
- Retail Pharmacies
Frequently Asked Questions
The Europe Dengue Treatment Market is segmented based on Segmentation Type,Strains,Severity,Route of Administration,End User,Age,Gender,Mode of Purchase,Distribution Channel.
Europe Dengue Treatment Market was valued at USD 91.62(Revenue in USD Million) in 2022.
Europe Dengue Treatment Market is projected to grow at a CAGR of 11.09% during the forecast period of 2024 to 2032.
The estimated market value of the Europe Dengue Treatment Market for final year is USD 193.61 (USD Million).
Europe Dengue Treatment Market Company Profiling
Frequently Asked Questions
The Europe Dengue Treatment Market is segmented based on Segmentation Type,Strains,Severity,Route of Administration,End User,Age,Gender,Mode of Purchase,Distribution Channel.
Europe Dengue Treatment Market was valued at USD 91.62(Revenue in USD Million) in 2022.
Europe Dengue Treatment Market is projected to grow at a CAGR of 11.09% during the forecast period of 2024 to 2032.
The estimated market value of the Europe Dengue Treatment Market for final year is USD 193.61 (USD Million).
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.